519353
BANSTEA
Start SIP
Invest Now
Start SIP in BANSTEA
Performance
- Low
- ₹16
- High
- ₹16
- 52 Week Low
- ₹6
- 52 Week High
- ₹16
- Open Price₹16
- Previous Close₹16
- Volume200
- 50 DMA₹11.16
- 100 DMA₹9.10
- 200 DMA₹7.44
Investment Returns
- Over 1 Month 0%
- Over 3 Month + 83.56%
- Over 6 Month + 183.21%
- Over 1 Year + 182.71%
Smart Investing Starts Here Start SIP with Novyra Pharmachem for Steady Growth!
Novyra Pharmachem Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -146.6
- PEG Ratio
- 5.3
- Market Cap Cr
- 10
- P/B Ratio
- 1.7
- Average True Range
- 0.24
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- 1.79
- RSI
- 93.95
- MFI
- 100
Novyra Pharmachem Financials
Novyra Pharmachem Technicals
EMA & SMA
Current Price
₹15.86
0
(0%)
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹13.95
- 50 Day
- ₹11.16
- 100 Day
- ₹9.10
- 200 Day
- ₹7.44
Resistance and Support
15.86
- R3 15.86
- R2 15.86
- R1 15.86
- S1 15.86
- S2 15.86
- S3 15.86
Novyra Pharmachem Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-01-26 | Quarterly Results | (Revised) |
| 2025-11-19 | Others | 1. To approve change of Object Clause of the MOA of the Company, subject to approval of shareholders. 2. Approve change of Name of the Company. 3. Draft Notice of the Postal Ballot for seeking consent of the members. 4. Other business matters. |
| 2025-10-11 | Quarterly Results | |
| 2025-08-12 | Quarterly Results | |
| 2025-05-28 | Audited Results | (Revised) |
Novyra Pharmachem F&O
About Novyra Pharmachem
- NSE Symbol
- BANSTEA
- BSE Symbol
- 519353
- ISIN
- INE856E01019
Similar Stocks to Novyra Pharmachem
Novyra Pharmachem FAQs
Novyra Pharmachem share price is ₹15 As on 06 February, 2026 | 08:01
The Market Cap of Novyra Pharmachem is ₹10 Cr As on 06 February, 2026 | 08:01
The P/E ratio of Novyra Pharmachem is -146.6 As on 06 February, 2026 | 08:01
The PB ratio of Novyra Pharmachem is 1.7 As on 06 February, 2026 | 08:01
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.